We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-1.75%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$892M
AUM Growth
+$114M
Cap. Flow
+$142M
Cap. Flow %
15.87%
Top 10 Hldgs %
24.46%
Holding
5,559
New
1,359
Increased
1,658
Reduced
1,483
Closed
897

Sector Composition

Rank Sector Weight
1 Technology 9.8%
2 Healthcare 7.16%
3 Financials 6.42%
4 Consumer Discretionary 4.97%
5 Communication Services 4.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRT
3851
Trio-Tech International
TRT
$113M
$2K ﹤0.01%
800
-1,110
-58% -$2.22K
TRUE
3852
DELISTED
TrueCar
TRUE
$2K ﹤0.01%
100
-12,656
-99% -$211K
TRX icon
3853
TRX Gold Corp
TRX
$344M
$2K ﹤0.01%
1,195
-570
-32% -$1.3K
TSEM icon
3854
Tower Semiconductor
TSEM
$28.5B
$2K ﹤0.01%
203
-2,097
-91% -$22.3K
TTSH
3855
DELISTED
Tile Shop Holdings
TTSH
$2K ﹤0.01%
200
-7,795
-97% -$87K
TURN
3856
DELISTED
180 Degree Capital
TURN
$2K ﹤0.01%
235
-65
-22% -$620
UBCP icon
3857
United Bancorp
UBCP
$96M
$2K ﹤0.01%
281
+181
+181% +$1.46K
ULH icon
3858
Universal Logistics Holdings
ULH
$529M
$2K ﹤0.01%
80
-1,192
-94% -$29.3K
BSIN
3859
Big Sky Industrial
BSIN
$63.3M
$2K ﹤0.01%
9
-9
-50% -$2.14K
UVV icon
3860
Universal Corp
UVV
$1.27B
$2K ﹤0.01%
54
-1,540
-97% -$79.4K
VEGI icon
3861
iShares MSCI Agriculture Producers ETF
VEGI
$147M
$2K ﹤0.01%
+85
New +$2.33K
VNDA icon
3862
Vanda Pharmaceuticals
VNDA
$302M
$2K ﹤0.01%
208
-718
-78% -$9.41K
VTHR icon
3863
Vanguard Russell 3000 ETF
VTHR
$4.86B
$2K ﹤0.01%
22
-21
-49% -$1.92K
VXRT
3864
DELISTED
Vaxart
VXRT
$2K ﹤0.01%
+63
New +$1.81K
WLFC icon
3865
Willis Lease Finance
WLFC
$1.29B
$2K ﹤0.01%
231
+108
+88% +$813
WRN
3866
Western Copper and Gold
WRN
$544M
$2K ﹤0.01%
3,300
XTLB
3867
XTL Biopharmaceuticals
XTLB
$7.22M
$2K ﹤0.01%
57
+20
+54% +$1.04K
YHGJ icon
3868
Yunhong Green CTI Ltd
YHGJ
$7.83M
$2K ﹤0.01%
52
-111
-68% -$4.71K
ORKA
3869
Oruka Therapeutics
ORKA
$5.96B
$2K ﹤0.01%
+1
New +$2.09K
CUTR
3870
DELISTED
Cutera, Inc.
CUTR
$2K ﹤0.01%
198
+172
+662% +$1.71K
NDP
3871
DELISTED
TORTOISE ENERGY INDEPENDENCE FUND, INC.
NDP
$2K ﹤0.01%
+13
New +$2.8K
AUMN
3872
DELISTED
Golden Minerals Company
AUMN
$2K ﹤0.01%
154
+40
+35% +$1.04K
ENSV
3873
DELISTED
Enservco Corp.
ENSV
$2K ﹤0.01%
49
+43
+717% +$2.07K
SDPI
3874
DELISTED
Superior Drilling Products Inc.
SDPI
$2K ﹤0.01%
386
SCTL
3875
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$2K ﹤0.01%
737
-607
-45% -$2.95K

Similar funds

Tower Research Capital (TRC)'s Q3 2014 Portfolio in Review

As of Q3 2014, Tower Research Capital (TRC) held 5,559 positions worth $892M, up 15% from $778M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) deployed $142M of net new capital in Q3 2014, opening 1,359 new positions and adding to 1,658 existing holdings. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 35,647 shares worth $9.81M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 5.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $106M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2014 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 35,647 shares worth $9.81M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q3 2014, an estimated $23.8M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $106M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Value ETF in Q3 2014, selling an estimated $9.03M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $892M portfolio in Q3 2014.
  • Tower Research Capital (TRC) opened 1,359 new positions and closed 897 in Q3 2014.
  • Tower Research Capital (TRC)'s portfolio value rose 15% quarter-over-quarter to $892M.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2014, filed 31 Oct 2014.